Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 287

1.

Biosynthesis of polyhydroxyalkanoates from sucrose by metabolically engineered Escherichia coli strains.

Sohn YJ, Kim HT, Baritugo KA, Song HM, Ryu MH, Kang KH, Jo SY, Kim H, Kim YJ, Choi JI, Park SK, Joo JC, Park SJ.

Int J Biol Macromol. 2020 Jan 27;149:593-599. doi: 10.1016/j.ijbiomac.2020.01.254. [Epub ahead of print]

PMID:
32001289
2.

Visfatin Induces Senescence of Human Dental Pulp Cells.

Ok CY, Park S, Jang HO, Takata T, Bae MK, Kim YD, Ryu MH, Bae SK.

Cells. 2020 Jan 12;9(1). pii: E193. doi: 10.3390/cells9010193.

3.

A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.

Chen LT, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Sameshima H, Kang YK, Boku N.

Gastric Cancer. 2019 Dec 20. doi: 10.1007/s10120-019-01034-7. [Epub ahead of print]

PMID:
31863227
4.

Control of nitrogen fixation in bacteria that associate with cereals.

Ryu MH, Zhang J, Toth T, Khokhani D, Geddes BA, Mus F, Garcia-Costas A, Peters JW, Poole PS, Ané JM, Voigt CA.

Nat Microbiol. 2020 Feb;5(2):314-330. doi: 10.1038/s41564-019-0631-2. Epub 2019 Dec 16.

PMID:
31844298
5.

Acute air pollution exposure alters neutrophils in never-smokers and at-risk humans.

Wooding DJ, Ryu MH, Li H, Alexis NE, Pena O, Carlsten C; Canadian Respiratory Research Network.

Eur Respir J. 2019 Dec 5. pii: 1901495. doi: 10.1183/13993003.01495-2019. [Epub ahead of print]

PMID:
31806722
6.

Harnessing atmospheric nitrogen for cereal crop production.

Bloch SE, Ryu MH, Ozaydin B, Broglie R.

Curr Opin Biotechnol. 2019 Nov 29;62:181-188. doi: 10.1016/j.copbio.2019.09.024. [Epub ahead of print] Review.

7.

Impact of L-carnitine on imatinib-related muscle cramps in patients with gastrointestinal stromal tumor.

Chae H, Ryu MH, Ma J, Beck M, Kang YK.

Invest New Drugs. 2019 Oct 18. doi: 10.1007/s10637-019-00860-x. [Epub ahead of print]

PMID:
31628586
8.

Association between the exposure to anti-angiogenic agents and tumour immune microenvironment in advanced gastrointestinal stromal tumours.

Yoo C, Ryu YM, Kim SY, Kim J, Ock CY, Ryu MH, Kang YK.

Br J Cancer. 2019 Nov;121(10):819-826. doi: 10.1038/s41416-019-0596-1. Epub 2019 Oct 14.

PMID:
31607749
9.

Clinical significance of MET gene amplification in metastatic or locally advanced gastric cancer treated with first-line fluoropyrimidine and platinum combination chemotherapy.

Seo S, Ryu MH, Ryoo BY, Park Y, Park YS, Na YS, Lee CW, Lee JK, Kang YK.

Chin J Cancer Res. 2019 Aug;31(4):620-631. doi: 10.21147/j.issn.1000-9604.2019.04.06.

10.

Langerhans cell histiocytosis of the mandible: two case reports and literature review.

Hwang DS, Lee JS, Kim UK, Park HR, Ryu MH, Lee JH, Jung YH, Kim GC.

J Korean Assoc Oral Maxillofac Surg. 2019 Jun;45(3):167-172. doi: 10.5125/jkaoms.2019.45.3.167. Epub 2019 Jun 28.

11.

Role of Resection Following Focal Progression with Standard Doses of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses.

Cho H, Ryu MH, Lee Y, Park YS, Kim KH, Kim JH, Park Y, Lee SM, Kim CW, Kim BS, Yoo MW, Kang YK.

Oncologist. 2019 Dec;24(12):e1443-e1449. doi: 10.1634/theoncologist.2019-0009. Epub 2019 Jul 17.

12.

Misdiagnosis of ameloblastoma in a patient with clear cell odontogenic carcinoma: a case report.

Park JC, Kim SW, Baek YJ, Lee HG, Ryu MH, Hwang DS, Kim UK.

J Korean Assoc Oral Maxillofac Surg. 2019 Apr;45(2):116-120. doi: 10.5125/jkaoms.2019.45.2.116. Epub 2019 Apr 29.

13.

Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.

Satoh T, Kang YK, Chao Y, Ryu MH, Kato K, Cheol Chung H, Chen JS, Muro K, Ki Kang W, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Tanimoto M, Chen LT, Boku N.

Gastric Cancer. 2020 Jan;23(1):143-153. doi: 10.1007/s10120-019-00970-8. Epub 2019 May 13.

14.

Intra-abdominal desmoid tumors mimicking gastrointestinal stromal tumors - 8 cases: A case report.

Kim JH, Ryu MH, Park YS, Kim HJ, Park H, Kang YK.

World J Gastroenterol. 2019 Apr 28;25(16):2010-2018. doi: 10.3748/wjg.v25.i16.2010.

15.

Phase II Trial of Continuous Regorafenib Dosing in Patients with Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib.

Kim JJ, Ryu MH, Yoo C, Beck MY, Ma JE, Kang YK.

Oncologist. 2019 Nov;24(11):e1212-e1218. doi: 10.1634/theoncologist.2019-0033. Epub 2019 Apr 29.

16.

Particle Depletion Does Not Remediate Acute Effects of Traffic-related Air Pollution and Allergen. A Randomized, Double-Blind Crossover Study.

Wooding DJ, Ryu MH, Hüls A, Lee AD, Lin DTS, Rider CF, Yuen ACY, Carlsten C.

Am J Respir Crit Care Med. 2019 Sep 1;200(5):565-574. doi: 10.1164/rccm.201809-1657OC.

PMID:
30974969
17.

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers.

Park JH, Lee JS, Koo H, Kim JE, Ahn JH, Ryu MH, Park SR, Yoon SK, Lee JC, Hong YS, Kim SY, Kim KP, Yoo CH, Hong JY, Lee JL, Jung KH, Rhyoo BY, Kim TW.

J Cancer Educ. 2019 Feb 28. doi: 10.1007/s13187-019-01494-6. [Epub ahead of print]

PMID:
30820925
18.

Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience.

Kim JH, Ryu MH, Yoo C, Chae H, Na H, Beck M, Kim BS, Yoo MW, Yook JH, Kim BS, Kim KH, Kim CW, Kang YK.

Cancer Med. 2019 Mar;8(3):1034-1043. doi: 10.1002/cam4.1994. Epub 2019 Jan 28.

19.

Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4).

Boku N, Ryu MH, Kato K, Chung HC, Minashi K, Lee KW, Cho H, Kang WK, Komatsu Y, Tsuda M, Yamaguchi K, Hara H, Fumita S, Azuma M, Chen LT, Kang YK.

Ann Oncol. 2019 Feb 1;30(2):250-258. doi: 10.1093/annonc/mdy540.

20.

Preserving Orbicularis Branches of the Zygomatic Nerve with the Orbicularis Oculi Muscle-Superficial Musculoaponeurotic System Flap Complex in Facelift Surgery.

Ryu MH, Kahng D, Khoo LS, Lao WW.

Plast Reconstr Surg Glob Open. 2018 Oct 4;6(10):e1961. doi: 10.1097/GOX.0000000000001961. eCollection 2018 Oct.

21.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.

Muro K, Van Cutsem E, Narita Y, Pentheroudakis G, Baba E, Li J, Ryu MH, Zamaniah WIW, Yong WP, Yeh KH, Kato K, Lu Z, Cho BC, Nor IM, Ng M, Chen LT, Nakajima TE, Shitara K, Kawakami H, Tsushima T, Yoshino T, Lordick F, Martinelli E, Smyth EC, Arnold D, Minami H, Tabernero J, Douillard JY.

Ann Oncol. 2019 Jan 1;30(1):19-33. doi: 10.1093/annonc/mdy502.

22.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.

Muro K, Lordick F, Tsushima T, Pentheroudakis G, Baba E, Lu Z, Cho BC, Nor IM, Ng M, Chen LT, Kato K, Li J, Ryu MH, Zamaniah WIW, Yong WP, Yeh KH, Nakajima TE, Shitara K, Kawakami H, Narita Y, Yoshino T, Van Cutsem E, Martinelli E, Smyth EC, Arnold D, Minami H, Tabernero J, Douillard JY.

Ann Oncol. 2019 Jan 1;30(1):34-43. doi: 10.1093/annonc/mdy498.

23.

Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3).

Seo S, Ryu MH, Park YS, Ahn JY, Park Y, Park SR, Ryoo BY, Lee GH, Jung HY, Kang YK.

Gastric Cancer. 2019 May;22(3):527-535. doi: 10.1007/s10120-018-0891-1. Epub 2018 Nov 1.

PMID:
30386954
24.

Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design.

Moehler M, Ryu MH, Dvorkin M, Lee KW, Coşkun HŞ, Wong R, Chung HC, Poltoratsky A, Tsuji A, Yen CJ, Muntean AS, Le Sourd S, Vaccaro GM, Overton L, Boku N, Wainberg ZA, Patel M, Sharma M, Xiong H, Conti I, Taieb J, Bang YJ.

Future Oncol. 2019 Feb;15(6):567-577. doi: 10.2217/fon-2018-0668. Epub 2018 Oct 31.

25.

RhoGAP domain-containing fusions and PPAPDC1A fusions are recurrent and prognostic in diffuse gastric cancer.

Yang H, Hong D, Cho SY, Park YS, Ko WR, Kim JH, Hur H, Lee J, Kim SJ, Kwon SY, Lee JH, Park DY, Song KS, Chang H, Ryu MH, Cho KS, Kang JW, Kook MC, Thiessen N, He A, Mungall A, Han SU, Kim HK.

Nat Commun. 2018 Oct 25;9(1):4439. doi: 10.1038/s41467-018-06747-4.

26.
27.

Reframing the Etiology of Facial Sagging from a Facelift Perspective.

Ryu MH, Khoo LS, Lee JO, Li D.

Plast Reconstr Surg Glob Open. 2018 Jul 13;6(7):e1831. doi: 10.1097/GOX.0000000000001831. eCollection 2018 Jul. No abstract available.

28.

Study on the copper(II)-doped MIL-101(Cr) and its performance in VOCs adsorption.

Wang D, Wu G, Zhao Y, Cui L, Shin CH, Ryu MH, Cai J.

Environ Sci Pollut Res Int. 2018 Oct;25(28):28109-28119. doi: 10.1007/s11356-018-2849-6. Epub 2018 Aug 1.

PMID:
30069779
29.

Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.

Bang YJ, Ruiz EY, Van Cutsem E, Lee KW, Wyrwicz L, Schenker M, Alsina M, Ryu MH, Chung HC, Evesque L, Al-Batran SE, Park SH, Lichinitser M, Boku N, Moehler MH, Hong J, Xiong H, Hallwachs R, Conti I, Taieb J.

Ann Oncol. 2018 Oct 1;29(10):2052-2060. doi: 10.1093/annonc/mdy264.

30.

Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.

Bazarsad S, Kim JY, Zhang X, Kim KY, Lee DY, Ryu MH, Kim J.

Yonsei Med J. 2018 Aug;59(6):717-726. doi: 10.3349/ymj.2018.59.6.717.

31.

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.

Abou-Alfa GK, Meyer T, Cheng AL, El-Khoueiry AB, Rimassa L, Ryoo BY, Cicin I, Merle P, Chen Y, Park JW, Blanc JF, Bolondi L, Klümpen HJ, Chan SL, Zagonel V, Pressiani T, Ryu MH, Venook AP, Hessel C, Borgman-Hagey AE, Schwab G, Kelley RK.

N Engl J Med. 2018 Jul 5;379(1):54-63. doi: 10.1056/NEJMoa1717002.

32.

Retrospective clinical study of multiple keratocystic odontogenic tumors in non-syndromic patients.

Hwang DS, Kim YH, Kim UK, Ryu MH, Kim GC.

J Korean Assoc Oral Maxillofac Surg. 2018 Jun;44(3):107-111. doi: 10.5125/jkaoms.2018.44.3.107. Epub 2018 Jun 26.

33.

A Prospective Randomized Comparison of a Covered Metallic Ureteral Stent and a Double-J Stent for Malignant Ureteral Obstruction.

Kim JW, Hong B, Shin JH, Park J, Kim JH, Gwon DI, Ryu MH, Ryoo BY.

Korean J Radiol. 2018 Jul-Aug;19(4):606-612. doi: 10.3348/kjr.2018.19.4.606. Epub 2018 Jun 14.

34.

Prognostic impact of extranodal extension in stage 1B gastric carcinomas.

Lee IS, Kang HJ, Park YS, Ryu MH, Yook JH, Kang YK, Kim BS.

Surg Oncol. 2018 Jun;27(2):299-305. doi: 10.1016/j.suronc.2018.05.014. Epub 2018 May 8.

PMID:
29937185
35.

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.

Shitara K, Özgüroğlu M, Bang YJ, Di Bartolomeo M, Mandalà M, Ryu MH, Fornaro L, Olesiński T, Caglevic C, Chung HC, Muro K, Goekkurt E, Mansoor W, McDermott RS, Shacham-Shmueli E, Chen X, Mayo C, Kang SP, Ohtsu A, Fuchs CS; KEYNOTE-061 investigators.

Lancet. 2018 Jul 14;392(10142):123-133. doi: 10.1016/S0140-6736(18)31257-1. Epub 2018 Jun 4.

PMID:
29880231
36.

Reconstruction of cheek mucosal defect with a buccal fat pad flap in a squamous cell carcinoma patient: a case report and literature review.

Hwang DS, Park J, Kim UK, Park HR, Kim GC, Ryu MH.

Maxillofac Plast Reconstr Surg. 2018 May 25;40(1):11. doi: 10.1186/s40902-018-0150-8. eCollection 2018 Dec.

37.

The Flavonoid Jaceosidin from Artemisia princeps Induces Apoptotic Cell Death and Inhibits the Akt Pathway in Oral Cancer Cells.

Han HY, Kim HJ, Jeong SH, Kim J, Jeong SH, Kim GC, Hwang DS, Kim UK, Ryu MH.

Evid Based Complement Alternat Med. 2018 May 13;2018:5765047. doi: 10.1155/2018/5765047. eCollection 2018.

38.

Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives.

Taieb J, Moehler M, Boku N, Ajani JA, Yañez Ruiz E, Ryu MH, Guenther S, Chand V, Bang YJ.

Cancer Treat Rev. 2018 May;66:104-113. doi: 10.1016/j.ctrv.2018.04.004. Epub 2018 Apr 22. Review.

39.

Comparison of efficacy and tolerance between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer: Study protocol for a randomized controlled trial.

Lee KW, Zang DY, Ryu MH, Kim KH, Kim MJ, Han HS, Koh SA, Park JH, Kim JW, Nam BH, Choi IS.

Contemp Clin Trials Commun. 2017 Aug 18;8:55-61. doi: 10.1016/j.conctc.2017.08.006. eCollection 2017 Dec.

40.

Use of complementary and alternative medicine by lymphoma survivors in South Korea.

Kim K, Kim SH, Ok ON, Kim IR, Lee S, Kim SH, Kim WS, Ryu MH, Lee MH.

Eur J Oncol Nurs. 2018 Apr;33:91-96. doi: 10.1016/j.ejon.2018.01.012. Epub 2018 Feb 20.

PMID:
29551184
41.

A Pressure Test to Make 10 Molecules in 90 Days: External Evaluation of Methods to Engineer Biology.

Casini A, Chang FY, Eluere R, King AM, Young EM, Dudley QM, Karim A, Pratt K, Bristol C, Forget A, Ghodasara A, Warden-Rothman R, Gan R, Cristofaro A, Borujeni AE, Ryu MH, Li J, Kwon YC, Wang H, Tatsis E, Rodriguez-Lopez C, O'Connor S, Medema MH, Fischbach MA, Jewett MC, Voigt C, Gordon DB.

J Am Chem Soc. 2018 Mar 28;140(12):4302-4316. doi: 10.1021/jacs.7b13292. Epub 2018 Mar 16.

PMID:
29480720
42.

Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy.

Kang YK, Ryu MH, Park SH, Kim JG, Kim JW, Cho SH, Park YI, Park SR, Rha SY, Kang MJ, Cho JY, Kang SY, Roh SY, Ryoo BY, Nam BH, Jo YW, Yoon KE, Oh SC.

Ann Oncol. 2018 May 1;29(5):1220-1226. doi: 10.1093/annonc/mdy055.

43.

Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).

Jung M, Ryu MH, Oh DY, Kang M, Zang DY, Hwang IG, Lee KW, Kim KH, Shim BY, Song EK, Sym SJ, Han HS, Park YL, Kim JS, Lee HW, Lee MH, Koo DH, Song HS, Lee N, Yang SH, Choi DR, Hong YS, Lee KE, Maeng CH, Baek JH, Kim S, Kim YH, Rha SY, Cho JY, Kang YK.

Gastric Cancer. 2018 Sep;21(5):819-830. doi: 10.1007/s10120-018-0806-1. Epub 2018 Feb 9.

PMID:
29427038
44.

Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11.

Kim HS, Ryu MH, Zang DY, Park SR, Han B, Kang WK, Rha SY, Jung M, Kim JS, Kang BW, Lee KH, Rho SY, Kim JH, Kim KC, Cho JW, Choi DR, Lim H, Kang HS, Soh JS, Kim MJ, Seo J, Kang YK.

Gastric Cancer. 2018 Sep;21(5):802-810. doi: 10.1007/s10120-018-0794-1. Epub 2018 Jan 25.

PMID:
29372461
45.

Inhaled diesel exhaust alters the allergen-induced bronchial secretome in humans.

Mookherjee N, Piyadasa H, Ryu MH, Rider CF, Ezzati P, Spicer V, Carlsten C.

Eur Respir J. 2018 Jan 25;51(1). pii: 1701385. doi: 10.1183/13993003.01385-2017. Print 2018 Jan.

46.

Prophylactic benefits of systemically delivered simvastatin treatment in a house dust mite challenged murine model of allergic asthma.

Jha A, Ryu MH, Oo O, Bews HJ, Carlson JC, Schwartz J, Basu S, Wong CS, Halayko AJ.

Br J Pharmacol. 2018 Apr;175(7):1004-1016. doi: 10.1111/bph.14140. Epub 2018 Feb 27.

47.

The Inclusion of Orbicularis Oculi Muscle in the SMAS Flap in Asian Facelift: Anatomical Consideration of Orbicularis Muscle and Zygomaticus Major Muscle.

Ryu MH, Moon VA, Yin W.

Aesthetic Plast Surg. 2018 Apr;42(2):471-478. doi: 10.1007/s00266-017-1056-z. Epub 2018 Jan 4.

PMID:
29302733
48.

Nitidine chloride acts as an apoptosis inducer in human oral cancer cells and a nude mouse xenograft model via inhibition of STAT3.

Kim LH, Khadka S, Shin JA, Jung JY, Ryu MH, Yu HJ, Lee HN, Jang B, Yang IH, Won DH, Kwon HJ, Jeong JH, Hong SD, Cho NP, Cho SD.

Oncotarget. 2017 Aug 24;8(53):91306-91315. doi: 10.18632/oncotarget.20444. eCollection 2017 Oct 31.

49.

Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors.

Na YS, Ryu MH, Yoo C, Lee JK, Park JM, Lee CW, Lee SY, Shin YK, Ku JL, Ahn SM, Kang YK.

Oncotarget. 2017 Sep 11;8(44):76712-76721. doi: 10.18632/oncotarget.20816. eCollection 2017 Sep 29.

50.

Smartphone-Driven Low-Power Light-Emitting Device.

An HJ, Kim KW, Ryu MH, Oh HY, Kim NG, Park KJ.

J Healthc Eng. 2017;2017:5076965. doi: 10.1155/2017/5076965. Epub 2017 Apr 13.

Supplemental Content

Support Center